Evidence map›Paper›PMID 36983350›Full record

ArticleJournal of clinical medicine2023

Optical Coherence Tomography Angiography in Macular Holes Autologous Retinal Transplant.

Virgilio Morales-Canton, Daniela Meizner-Grezemkovsky, Pablo Baquero-Ospina, Nicolás Crim, Lihteh Wu

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Virgilio Morales-CantonRetina Department, Asociación Para Evitar la Ceguera en México, "Hospital Dr. Luis Sanchez Bulnes", IAP, Mexico City 04030, Mexico.
Daniela Meizner-GrezemkovskyRetina Department, Asociación Para Evitar la Ceguera en México, "Hospital Dr. Luis Sanchez Bulnes", IAP, Mexico City 04030, Mexico.
Pablo Baquero-OspinaRetina Department, Asociación Para Evitar la Ceguera en México, "Hospital Dr. Luis Sanchez Bulnes", IAP, Mexico City 04030, Mexico.ORCID 0000-0001-6262-9558
Nicolás CrimRetina Department, Sanatorio del Salvador, Córdoba X5004, Argentina.
Lihteh WuAsociados de Macula, Vitreo y Retina de Costa Rica, San José 10102, Costa Rica.ORCID 0000-0002-3387-7058
Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes · MXUniversidad del Salvador · ARUniversity of Illinois Urbana-Champaign · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we compare the post-operative macular microvascular parameters (vascular density and foveal avascular zone) in eyes with refractory macular hole (MH) that underwent pars plana vitrectomy and autologous retinal transplant (ART) with the fellow unoperated eye. We conducted a retrospective case control study of six consecutive patients who underwent pars plana vitrectomy and ART with at least six months of post-operative follow-up. Pre-operatively, all eyes underwent SD-OCT (Spectral Domain Optical Coherence Tomography) examination. Post-operative OCT-A analyses included vascular density (VD) and the foveal avascular zone (FAZ) area. Six patients with a mean age of 63.7 ± 14.3 years were included. The mean follow-up was 24 months (range 6-30 months). The pre-operative BCVA (best-corrected visual acuity) was 0.99 ± 0.46 logMAR and 1.02 ± 0.23 logMAR at the last post-operative visit (

Indexed as

autologous neurosensory retina transplantfoveal avascular zonemacular hole surgeryOCT angiographyrefractory macular holevascular density

Identifiers

PMID36983350
PMCPMC10056546
OpenAlexW4327964389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.